News

This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.Video Transcript:Editor's note: The below transcript has been lightly edited for clarity.Vikas Chopra, MD:Yeah. I mean, if we can cure blindness, that would be amazing. So, you know, we are, of course, moving in that direction with, you know, … [Read more...] about Part 7: Ask the Experts: What problem in ophthalmology do you wish there was a solution for?

A recent study that compared 2 anti-vascular endothelial growth factor drugs for treating diabetic macular edema (DME) found that brolucizumab (Beovu, Novartis) was non-inferior in functional outcomes and superior to aflibercept (Eylea, Regeneron Pharmaceuticals) in anatomic parameters,1 according to first author Leonardo B. Justino from the Division of Medicine, Federal … [Read more...] about Brolucizumab shows promise over aflibercept for diabetic macular edema in meta-analysis

In response to a report of foreign material found in a sealed vial, Alcon Laboratories has initiated a voluntary recall of Lot 10101 of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count.Alcon evaluated a consumer complaint of foreign material observed inside a sealed single use vial and determined the material to be fungal in nature.The company issued the … [Read more...] about Alert: Alcon voluntarily recalls Systane Ultra PF lot due to potential fungal contamination

This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.Video Transcript:Editor's note: The below transcript has been lightly edited for clarity.Fatemah Rajaii, MD, PhD:I think it would be awesome if we had a way to identify patients once they develop or have onset of thyroid eye disease, develop … [Read more...] about Part 6: Ask the Experts: What problem in ophthalmology do you wish there was a solution for?

In 2024, Modern Retina covered news from around the globe on clinical trials, technology in retina, trending topics in ophthalmology, and retina conferences. Let’s look back on some of the top stories of the year as we gear up for an incredible 2025.GA and AMDAge-related macular degeneration (AMD) and geographic atrophy (GA) continue to be major areas of development as … [Read more...] about Eyecare wrapped: Top stories from Modern Retina in 2024

VEGF-A therapy has revolutionized treatment and visual outcomes for patients with neovascular age-related macular degeneration (nAMD). Ranibizumab, the first anti–VEGF-A agent to be FDA approved, was introduced more than 18 years ago. Despite the introduction of additional nAMD therapies over the years, visual outcomes obtained have been comparable to outcomes from the ANCHOR … [Read more...] about Beyond VEGF: A Next-generation therapies aim to enhance vision and quality of life in neovascular AMD

Thelaziasis, an ocular parasitic infection caused by Thelazia callipaeda, poses unique diagnostic and therapeutic challenges for ophthalmologists.This zoonotic disease, transmitted by Drosophilid flies, is associated with a spectrum of ocular symptoms ranging from mild irritation to severe inflammation. Here, we present a case of Thelazia callipaeda infection in a 41-year-old … [Read more...] about Study: Thelazia callipaeda infection in a 41-year-old female patient